Lupus & antiphospholipid syndrome

Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes

Ann Rheum DisPublished Prospective inception cohort study

Authors' conclusion

Four discrete SLE patient longitudinal autoantibody clusters were predictive of long-term disease activity, organ involvement, treatment requirements and mortality risk.

Study context

Population
Patients with systemic lupus erythematosus (SLE) from a multinational inception cohort, data within 15 months of diagnosis and at 3-year and 5-year follow-upinception cohort
Participants
805 patients
Exposure
Longitudinal autoantibody clusters 1, 3 and 4 vs cluster 2
  • Cluster 1n = 137
  • Cluster 2n = 376reference
  • Cluster 3n = 80
  • Cluster 4n = 212
Outcome
Clinical outcomes and survival by longitudinal autoantibody cluster
Follow-up
10-year follow-up
Methodological detailsmultinational, machine learning, K-means clustering on PCA-transformed longitudinal autoantibody profiles, Cox proportional hazards model adjusted for age of disease onset
  • Multinational
  • Machine learning
  • K-means clustering on PCA-transformed longitudinal autoantibody profiles
  • Cox proportional hazards model adjusted for age of disease onset

Main finding

As reported in the abstract

Survival (lower survival vs cluster 2)
Each group vs cluster 2AHR, event not clear (lower survival), adjusted for age of disease onset (95% CI)P value
Cluster 1
2.60(1.12–6.05)
P = 0.03
Cluster 3
2.87(1.22–6.74)
P = 0.02

Observational data: associations, not effects.

Further findings

Clinical outcomes by cluster · year 10

Cluster 1: highest cumulative disease activity and immunosuppressants/biologics use
Cluster 2: lowest disease activity, frequency of LN and immunosuppressants/biologics use
Cluster 3: highest frequency of seizures and hypocomplementaemia
Cluster 4: also high disease activity

Original publication

Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes. Ann Rheum Dis. Published 21 April 2023. doi:10.1136/ard-2022-223808

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.